CVE:PDP

Pediapharm (PDP) Stock Price, News & Analysis

C$0.30
+0.01 (+1.69%)
(As of 12/18/2018)
Today's Range
C$0.29
C$0.31
50-Day Range
C$0.30
C$0.30
52-Week Range
C$0.25
C$0.49
Volume
26,000 shs
Average Volume
100,369 shs
Market Capitalization
C$66.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PDP stock logo

About Pediapharm Stock (CVE:PDP)

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.

PDP Stock Price History

PDP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive PDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediapharm and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$11.16 million
Cash Flow
C$0.01 per share
Book Value
C($0.01) per share

Miscellaneous

Free Float
N/A
Market Cap
C$66.36 million
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Sylvain Chretien (Age 54)
    Pres, CEO & Director
  • Mr. Roland Boivin
    Chief Financial Officer
  • Mr. Richard Labelle
    VP of Sales & Marketing
  • Mr. Benoît Hébert (Age 50)
    VP of Bus. Devel. & Licensing
  • Mr. Normand Chartrand (Age 59)
    Consultant

PDP Stock Analysis - Frequently Asked Questions

How have PDP shares performed in 2024?

Pediapharm's stock was trading at C$0.30 on January 1st, 2024. Since then, PDP shares have increased by 0.0% and is now trading at C$0.30.
View the best growth stocks for 2024 here
.

Is Pediapharm a good dividend stock?

Pediapharm (CVE:PDP) pays an annual dividend of C$0.14 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Pediapharm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediapharm investors own include eMagin (EMAN), Eleven Biotherapeutics (EBIO), Coro Mining (COP), Champion Iron (CIA), Anavex Life Sciences (AVXL), AVEO Pharmaceuticals (AVEO), Asterias Biotherapeutics (AST) and Apellis Pharmaceuticals (APLS).

How do I buy shares of Pediapharm?

Shares of PDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:PDP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners